← Browse by Condition

Medical Condition

follicular lymphoma

Total Trials

11

Recruiting Now

11

Trial Phases

Phase 2, Phase 1, Phase 2, Phase 1

NCT05281809 Phase 2

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

NCT05006716 Phase 1, Phase 2

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

United States, Austr...

BeOne Medicines

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

Adaptive Biotechnologies

NCT04468841 Phase 1

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

Memorial Sloan Kettering Cance...

NCT05805605 Phase 2

Allo HSCT Using RIC and PTCy for Hematological Diseases

Masonic Cancer Center, Univers...

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Children's Hospital Medical Ce...

NCT01804686 Phase 3

A Long-term Extension Study of PCI-32765 (Ibrutinib)

United States, Argen...

Janssen Research & Development...

Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

Argentina, Australia...

NCT06510361 Phase 2

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Beth Israel Deaconess Medical ...

NCT06108232 Phase 2

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

M.D. Anderson Cancer Center

NCT07029217 Phase 3

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Memorial Sloan Kettering Cance...